AI Summary Fibrosis scores such as FIB-4, FIB-3, APRI, and ELF use routine blood results, and sometimes age, to estimate liver scarring without a biopsy. They are good at ruling out advanced fibrosis but weaker at confirming it, and they do not measure liver fat or inflammation. A low result makes advanced scarring unlikely; an in-between or high result often leads to FibroScan, imaging, or a specialist visit. Treatment targets the underlying cause.
Source: www.liverdirectory.com
Medically Reviewed.
Fibrosis scores turn routine blood results, and in some cases special fibrosis markers, into one number. That number estimates your chance of significant liver scarring (fibrosis) or cirrhosis.
This page introduces the group, compares the main scores, and points you to the detailed guide on FIB-3 and FIB-4.
Below, you will find key facts, score ranges, what happens after each result, and answers to common questions.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Liver Scarring Explained
Fibrosis is scar tissue in the liver. It builds up when the liver is injured or inflamed again and again and tries to repair itself. Chronic liver disease often moves through four stages: hepatitis (inflammation), fibrosis, cirrhosis, and liver failure. Cirrhosis is severe, lasting scarring.
Early fibrosis often causes no symptoms or only mild ones. That is why doctors look for it with tests. A fibrosis score is one of those tests. It combines blood results, and sometimes your age, into a number that estimates how likely it is that you have advanced scarring.
Most scores need only a blood draw, so there is no procedure. Doctors use them for people with chronic liver conditions such as hepatitis B, hepatitis C, fatty liver disease, and alcohol-related liver disease.
A score is an estimate, not a diagnosis. Your care team reads it with your other results, such as liver function tests, and may add imaging. This group sits within Medical Scores.
FIB-4, APRI, and ELF Cutoffs
Each score has a low, in-between, and high range. Labs and guidelines sometimes use slightly different cutoffs, so follow your own report.
| Score | What it uses | Lower risk | In-between | Higher risk |
|---|---|---|---|---|
| FIB-4 | Age, AST, ALT, platelets | Below 1.45 | 1.45 to 3.25 | Above 3.25 |
| FIB-3 | Age, AST, ALT, platelets | Below 1.3 | 1.3 to 2.67 | Above 2.67 |
| APRI | AST and platelets | Below 0.5 | 0.5 to 1.5 | Above 1.5 |
| ELF | Hyaluronic acid, PIIINP, TIMP-1 | Below 7.7 | 7.7 to 9.8 | Above 9.8 |
Lower risk means advanced scarring is unlikely. Higher risk means advanced fibrosis or cirrhosis is more likely and needs further evaluation. Neither result confirms a stage on its own.
Blood-Based Fibrosis Tests
Each score answers the same question, how likely is advanced scarring, from different blood results.
FIB-4 combines your age with AST, ALT, and platelet count. FIB-3 is a related calculation with its own equation and ranges. Both use routine blood work, and doctors use them to watch fibrosis over time or to help avoid a biopsy. The detailed guide shows the equations and ranges.
APRI stands for AST-to-platelet ratio index. It uses just two routine values: AST, a liver enzyme, and platelet count. A score below 0.5 makes cirrhosis unlikely. A score above 1.5 makes advanced fibrosis or cirrhosis more likely. A score from 0.5 to 1.5 needs more testing. Doctors use APRI, along with FIB-4, as a first step before other testing.
The ELF test is a blood test that measures three markers of scarring: hyaluronic acid, PIIINP, and TIMP-1. A formula combines them into one score from 0 to 10, and higher scores mean more severe fibrosis. A score below 7.7 is low risk. A score from 7.7 to 9.8 is moderate risk and may lead to FibroScan, ultrasound, or other imaging. A score above 9.8 is high risk, and a specialist evaluation is usually needed. Unlike a biopsy, ELF is painless and can be repeated over time.
Understanding Your Result
What happens next depends on where your result falls and on your overall health.
A low score suggests that advanced scarring is unlikely. You may not need an immediate referral to a specialist. Your doctor may still recommend repeat testing, depending on your risk factors, such as ongoing viral hepatitis or fatty liver disease.
An in-between score cannot rule advanced scarring in or out. Your doctor usually orders a second test, such as a [FibroScan](/liver-tests/imaging-non-invasive-testing/elastography-fibrosis-testing/fibroscan), another elastography method, or imaging. Some cases may need a [liver biopsy](/liver-tests/invasive-testing/liver-biopsy) to clarify the stage.
A high score makes advanced fibrosis or cirrhosis more likely. It does not confirm the diagnosis. Expect a specialist evaluation and further testing to measure how much scarring is present and whether complications are a concern.
Treatment depends on the disease that caused the scarring. Examples include [direct-acting antivirals](/liver-therapies/viral-hepatitis-treatments/hcv-direct-acting-antivirals) for hepatitis C, or weight, diet, and metabolic care for fatty liver disease. Some early fibrosis can improve when the damage slows enough for the liver to recover. Cirrhosis is not reversible, but you can still slow or stop further damage.
Amsety Bars were designed for people with liver conditions by liver health experts. They offer a convenient way to add energy and nutrients to a liver-friendly diet. Ask your provider what fits your needs.
Explore Liver Health Nutrition Bars
Score Accuracy and Limitations
Fibrosis scores are useful screening and monitoring tools, but they have limits.
If your score is in the in-between or high range, a liver specialist can plan the next test with you. Use the specialist search below to find one.
Liver Health Coach
Personal Liver Health Records
Bring your scores and test dates to each visit so your care team can see how your results change over time.
Common Question
Blood tests can estimate the chance of fibrosis, but they cannot confirm its exact stage. Clinical guidelines recommend FIB-4 and APRI over no testing to detect significant and advanced fibrosis. If a result is unclear, your doctor may add FibroScan, imaging, or a biopsy.
A FIB-4 score below 1.45 is considered low risk. That suggests little or no significant scarring. Some labs use cutoffs near 1.3 and 2.6, so ask your doctor which range your lab uses.
An in-between score means the result is neither clearly low nor clearly high risk. The score alone cannot tell your doctor whether advanced scarring is present. Expect a follow-up test, such as FibroScan or another imaging method.
No. A high score means advanced fibrosis or cirrhosis is more likely, but it does not confirm either one. It signals that you need a full evaluation by a healthcare provider, often a liver specialist.
Some early fibrosis can improve if the damage slows enough for the liver to recover. Cirrhosis is permanent, but you can still slow or stop further damage. Treating the underlying cause is the main goal.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
